EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HMGB1 in Septic Muscle Atrophy: Roles and Therapeutic Potential for Muscle Atrophy and Regeneration

Si-Yuan Qi, Qiqi Wu, Peng-Hui Xiang, Chao-Yao Hou, Zhaofeng Kang, Meng-Qi Chen, Chengla Yi, Xiangjun Bai, Tianyu Li, Zhanfei Li, Wei-Ming Xie

Journal of Cachexia, Sarcopenia and Muscle · 2025-02 · 16 (1)

DOI: 10.1002/jcsm.13711 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 18.02.2025. Verfasst von Si-Yuan Qi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Trauma Center, Tongji Hospital, Tongji Medical College, Huazhong University…. Hauptthemen laut MEDLINE: HMGB1 Protein, Regeneration, Sepsis, Muscular Atrophy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund of Tongji Hospital of Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the treatment of septic myopathy presents significant challenges with implications for increased mortality rates and prolonged hospitalizations. Effective therapeutic strategies for septic myopathy remain elusive, highlighting an urgent need for novel therapeutic approaches. High‐mobility group box 1 (HMGB1) is a conserved nonhistone nuclear protein that is released passively from deceased cells or actively secreted by activated immune cells, influencing both infectious and noninfectious inflammatory responses. Studies have indicated that HMGB1 likely plays a pivotal role in the pathogenesis of septic myopathy by crucial pathways associated with muscle atrophy and contributing to muscle regeneration under certain conditions. This review aims to summarize the possible mechanisms of HMGB1 in muscle atrophy and its potential in muscle regeneration, providing a theoretical basis for HMGB1 treatment of septic myopathy. Research shows that the dual role of HMGB1 is related to its specific forms, which are influenced to varying degrees by environmental factors. HMGB1 is a key participant in septic muscle atrophy, whereas HMGB1 shows therapeutic potential in muscle regeneration. One key mechanism by which HMGB1 contributes to septic muscle atrophy is through the exacerbation of inflammation. HMGB1 can amplify the inflammatory response by promoting the release of pro‐inflammatory cytokines, which further damages muscle tissue. HMGB1 is also involved in promoting cell death in sepsis, which contributes to muscle degradation. Another important mechanism is the regulation of protein degradation systems. HMGB1 can activate the ubiquitin–proteasome system and autophagy–lysosome pathway, both of which are crucial for the breakdown of muscle proteins during atrophy. Conversely, targeting HMGB1 has shown the potential to ameliorate muscle atrophy in various diseases. For instance, HMGB1 has been shown to promote muscle vascular regeneration, modify stem cell status and enhance stem cell migration and differentiation, all of which are beneficial for muscle repair and recovery. Pharmacological inhibition of HMGB1 has been explored, with several drugs demonstrating efficacy in reducing inflammation and muscle degradation in sepsis models. These findings suggest that HMGB1 inhibition could be a viable therapeutic approach for septic myopathy. However, the function of promoting muscle regeneration in septic myopathy needs further research. HMGB1 emerges as a promising therapeutic target for the treatment of muscle atrophy in sepsis. This review focuses on identifying the correlation between HMGB1 and septic myopathy, analysing the possible role of HMGB1 in disease development and examining the feasibility of HMGB1 as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinRegenerationSepsisMuscular AtrophyHumansAnimalsMuscle, Skeletal

Stichwörter der Autor:innen

HMGB1clinical therapymuscle atrophysepsistissue regeneration

Substanzen

HMGB1 Protein

Autor:innen und Institutionen

  • Division of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Trauma Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Emergency and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Trauma Center, Peking University People's Hospital, Beijing, China.
  • Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University), Ministry of Education, Beijing, China.
  • National Center for Trauma Medicine of China, Beijing, China.

Förderung

  • Research Fund of Tongji Hospital of Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology

Zitieren

APA

Qi, S. Y., Wu, Q., Xiang, P. H., Hou, C. Y., Kang, Z., Chen, M. Q., Yi, C., Bai, X., Li, T., Li, Z., & Xie, W. M. (2025). HMGB1 in Septic Muscle Atrophy: Roles and Therapeutic Potential for Muscle Atrophy and Regeneration. Journal of Cachexia, Sarcopenia and Muscle, 16(1). https://doi.org/10.1002/jcsm.13711

Vancouver

Qi SY, Wu Q, Xiang PH, Hou CY, Kang Z, Chen MQ, et al. HMGB1 in Septic Muscle Atrophy: Roles and Therapeutic Potential for Muscle Atrophy and Regeneration. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(1). doi:10.1002/jcsm.13711

BibTeX
@article{Qi2025,
  author = {Qi, Si-Yuan and Wu, Qiqi and Xiang, Peng-Hui and Hou, Chao-Yao and Kang, Zhaofeng and Chen, Meng-Qi and Yi, Chengla and Bai, Xiangjun and Li, Tianyu and Li, Zhanfei and Xie, Wei-Ming},
  title = {HMGB1 in Septic Muscle Atrophy: Roles and Therapeutic Potential for Muscle Atrophy and Regeneration},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1002/jcsm.13711}
}
Kostenlos starten →